|
NIPA1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.201200E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.446140E-02 |
| Normal-vs-Stage2 |
6.600600E-01 |
| Normal-vs-Stage3 |
4.829200E-04 |
| Normal-vs-Stage4 |
1.787630E-01 |
| Stage1-vs-Stage2 |
1.167380E-01 |
| Stage1-vs-Stage3 |
7.569800E-02 |
| Stage1-vs-Stage4 |
6.925200E-01 |
| Stage2-vs-Stage3 |
1.293930E-02 |
| Stage2-vs-Stage4 |
4.569400E-01 |
| Stage3-vs-Stage4 |
1.504420E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.455890E-02 |
| Normal-vs-AfricanAmerican |
1.979580E-03 |
| Normal-vs-Asian |
5.027600E-01 |
| Caucasian-vs-AfricanAmerican |
1.877970E-01 |
| Caucasian-vs-Asian |
2.462200E-01 |
| AfricanAmerican-vs-Asian |
1.613400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.201000E-03 |
| Normal-vs-Female |
1.433780E-01 |
| Male-vs-Female |
5.980200E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.31560000000442E-05 |
| Normal-vs-Age(41-60Yrs) |
2.758300E-02 |
| Normal-vs-Age(61-80Yrs) |
2.115500E-02 |
| Normal-vs-Age(81-100Yrs) |
8.266500E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.877650E-03 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.039900E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.856300E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.531600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.425800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.658400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.518800E-01 |
| Normal-vs-Grade 2 |
1.077940E-02 |
| Normal-vs-Grade 3 |
2.688000E-02 |
| Normal-vs-Grade 4 |
1.660160E-02 |
| Grade 1-vs-Grade 2 |
7.043200E-01 |
| Grade 1-vs-Grade 3 |
8.571400E-01 |
| Grade 1-vs-Grade 4 |
5.847000E-01 |
| Grade 2-vs-Grade 3 |
6.349400E-01 |
| Grade 2-vs-Grade 4 |
6.013200E-01 |
| Grade 3-vs-Grade 4 |
4.037800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.681990E-01 |
| Normal-vs-ccB subtype |
3.639600E-03 |
| ccA subtype-vs-ccB subtype |
3.540200E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.705610E-02 |
| Normal-vs-N1 |
5.512600E-01 |
| N0-vs-N1 |
5.743200E-01 |
|
|
